Abiopharma

Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine

Merck Provides New Results for VERQUVO® (vericiguat) in Patients with Chronic Heart Failure and Reduced Ejection Fraction

Acoramidis Demonstrates Statistically Significant Reduction in Cardiovascular Mortality through Month 42 of the ATTRibute-CM Open Label Extension

NEOGEN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Neogen Corporation - NEOG

MSP Recovery Announces Strategic Term Sheet Providing Prospective Liquidity and Working Capital Aimed at Driving Future Growth

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Szot Matthew K 🔴 sold 2.0K shares of Cadrenal Therapeutics, Inc. (CVKD) at $14.00 Transaction Date: Aug 27, 2025 | Filing ID: 082821

Director Pham Quang X 🔴 sold 5.0K shares of Cadrenal Therapeutics, Inc. (CVKD) at $13.99 Transaction Date: Aug 27, 2025 | Filing ID: 082819

Cowan Elvia 🟢 acquired 12.6K shares (1 derivative) of Vaxcyte, Inc. (PCVX) at $30.79 Transaction Date: Aug 29, 2025 | Filing ID: 000006

Lynch Christopher S. 🔴 sold 8 shares of TENET HEALTHCARE CORP (THC) at $183.44 Transaction Date: Aug 28, 2025 | Filing ID: 000006

JEFFS ROGER 🔴 sold 60.0K shares of Axsome Therapeutics, Inc. (AXSM) at $122.30 ($7.3M) Transaction Date: Aug 27, 2025 | Filing ID: 000006

New Form 144 - RadNet, Inc. Filed: 2025-08-29 AccNo: 0001683168-25-006592 Size: 5 KB